Literature DB >> 19752332

Aromatase inhibitor-associated arthralgias.

Rowan T Chlebowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19752332     DOI： 10.1200/JCO.2009.23.3270

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  14 in total

1.  Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors.

Authors:  Melinda L Irwin; Brenda Cartmel; Cary P Gross; Elizabeth Ercolano; Fangyong Li; Xiaopan Yao; Martha Fiellin; Scott Capozza; Marianna Rothbard; Yang Zhou; Maura Harrigan; Tara Sanft; Kathryn Schmitz; Tuhina Neogi; Dawn Hershman; Jennifer Ligibel
Journal:  J Clin Oncol       Date:  2014-12-01       Impact factor: 44.544

2.  Online discussion of drug side effects and discontinuation among breast cancer survivors.

Authors:  Jun J Mao; Annie Chung; Adrian Benton; Shawndra Hill; Lyle Ungar; Charles E Leonard; Sean Hennessy; John H Holmes
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-01-16       Impact factor: 2.890

3.  Breast cancer survivorship symptom management: current perspective and future development.

Authors:  G van Londen; Eb Beckjord; Ma Dew; P Cuijpers; S Tadic; A Brufsky
Journal:  Breast Cancer Manag       Date:  2013-01

4.  Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors.

Authors:  Huijuan Mao; Ting Bao; Xueyong Shen; Qing Li; Christina Seluzicki; Eun-Ok Im; Jun J Mao
Journal:  Eur J Cancer       Date:  2018-07-14       Impact factor: 9.162

5.  Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors.

Authors:  Krupali Desai; Jun J Mao; Irene Su; Angela Demichele; Qing Li; Sharon X Xie; Philip R Gehrman
Journal:  Support Care Cancer       Date:  2012-05-15       Impact factor: 3.603

6.  Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors.

Authors:  Jun J Mao; H Irene Su; Rui Feng; Michelle L Donelson; Richard Aplenc; Timothy R Rebbeck; Frank Stanczyk; Angela DeMichele
Journal:  Breast Cancer Res       Date:  2011-01-20       Impact factor: 6.466

7.  The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia.

Authors:  Miyuki Kanematsu; Masami Morimoto; Junko Honda; Taeko Nagao; Misako Nakagawa; Masako Takahashi; Akira Tangoku; Mitsunori Sasa
Journal:  BMC Cancer       Date:  2011-10-10       Impact factor: 4.430

8.  Joint symptoms, aromatase inhibitor-related adverse reactions, are indirectly associated with decreased serum estradiol.

Authors:  Junko Honda; Miyuki Kanematsu; Misako Nakagawa; Masako Takahashi; Taeko Nagao; Akira Tangoku; Mitsunori Sasa
Journal:  Int J Surg Oncol       Date:  2011-05-26

Review 9.  Vitamin D and breast cancer: interpreting current evidence.

Authors:  Rowan T Chlebowski
Journal:  Breast Cancer Res       Date:  2011-08-16       Impact factor: 6.466

10.  Vitamin d: are we ready to supplement for breast cancer prevention and treatment?

Authors:  Katherine D Crew
Journal:  ISRN Oncol       Date:  2013-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.